首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1501篇
  免费   134篇
  国内免费   69篇
耳鼻咽喉   69篇
儿科学   67篇
妇产科学   52篇
基础医学   96篇
口腔科学   3篇
临床医学   218篇
内科学   560篇
皮肤病学   6篇
神经病学   51篇
特种医学   81篇
外科学   160篇
综合类   163篇
预防医学   55篇
眼科学   34篇
药学   69篇
中国医学   13篇
肿瘤学   7篇
  2024年   4篇
  2023年   22篇
  2022年   48篇
  2021年   58篇
  2020年   46篇
  2019年   79篇
  2018年   73篇
  2017年   71篇
  2016年   68篇
  2015年   65篇
  2014年   114篇
  2013年   106篇
  2012年   80篇
  2011年   92篇
  2010年   92篇
  2009年   69篇
  2008年   86篇
  2007年   93篇
  2006年   64篇
  2005年   47篇
  2004年   46篇
  2003年   38篇
  2002年   35篇
  2001年   37篇
  2000年   35篇
  1999年   21篇
  1998年   12篇
  1997年   16篇
  1996年   14篇
  1995年   8篇
  1994年   3篇
  1993年   7篇
  1992年   8篇
  1991年   6篇
  1990年   9篇
  1989年   7篇
  1988年   4篇
  1987年   4篇
  1986年   2篇
  1985年   2篇
  1984年   3篇
  1982年   1篇
  1981年   3篇
  1979年   1篇
  1978年   1篇
  1976年   2篇
  1973年   1篇
  1969年   1篇
排序方式: 共有1704条查询结果,搜索用时 0 毫秒
1.
ABSTRACT

Purpose

To investigate the effect of 1% tropicamide on anterior chamber aqueous flare (ACAF) measurements acquired with laser flare meter in patients with pseudoexfoliation.  相似文献   
2.
目的:比较普拉固和鱼油对高胆固醇血症患者的血脂、血粘度、血管内皮功能和心脑血管事件的影响。方法:对266例原发性高胆固醇血症患者经2周洗脱期后,随机分为两组,普拉固组,初服10mg,每晚一次,8周后若TC仍>5.2mmol/L,LDL—ch>3.12mmol/L,则加量至20mg/d,每8周再查血脂,以达到TC<5.2mmol/L,LDL—ch<3.12mmol/L的量作治疗量继续服用。鱼油组,服美国深海鱼油一日三次,一次3g,均于服药8周复查血脂、血粘度及血管内皮功能等并作16月随访。结果:治疗8周,TC,普拉固组下降26%,鱼油组下降12%(P<0.01)。LDL—ch,普拉固组下降31%,鱼油组下降11%(P<0.01),肱动脉流量介导的舒张与硝酸甘油介导的舒张,普拉固组分别增加104%和19%,鱼油组无明显改变。全血低切粘度,普拉固组减少23%,鱼油组减少10%(P<0.01)。平均随访16月,普拉固组中脑出血1例(0.8%),鱼油组发生心脑血管事件7例(5.3%),死亡1例(P<0.05)。两组均无明显的不良反应。结论:普拉固是一个安全有效的降脂药,能改善血管内皮功能,降低血粘度,减少高胆固醇血症病人心脑血管事件发生。  相似文献   
3.
The requirement for endoscopic access to a stricture is a major limitation of the endoscopic dilatation for the treatment of strictures in the gastrointestinal tract. We have developed the double‐balloon enteroscopy method that enables visualization of the entire small bowel. In addition, double‐balloon enteroscopy has a potential for the interventional therapy including dilatation of strictures. We present here a case of jejunal strictures in a 47‐year‐old woman with Crohn's disease successfully treated with a balloon catheter in combination with double‐balloon enteroscopy. Balloon dilation with double‐balloon enteroscopy is a promising method for the treatment of small bowel strictures in Crohn's disease.  相似文献   
4.
目的 探讨高频超声检测颈动脉内膜-中层厚度与肱动脉内皮依赖性舒张功能在动脉粥样硬化中的诊断价值.方法 冠状动脉造影的老年患者69例及青年志愿者20例,分别行颈动脉超声检查,同时采用充气加压法测定肱动脉血流介导的内径扩张值,超声测值与冠脉造影结果对照分析.结果 ①颈动脉内膜-中层厚度值随粥样硬化斑块的增多、冠脉狭窄程度的加重而增高;②动脉粥样硬化患者在内膜-中层厚度值增高之前即可出现内皮功能损伤,肱动脉内径扩张值降低早于内膜-中层厚度值增高之前出现,内径扩张值随冠脉狭窄程度加重而下降.结论 高频超声检测颈动脉内膜-中层厚度、内径扩张值诊断早期动脉粥样硬化敏感性高,并且有助于对冠脉狭窄程度作出判断.  相似文献   
5.
After removal of intraductal stones, a 10‐Fr or 7‐Fr pancreatic stent was placed in 16 patients with upstream ductal dilation proximal to a stricture of the main pancreatic duct. Stents were removed after a mean duration of 52.5 days. Nine patients underwent repeated stenting. About one year after removal of the initial stent, when the remaining upstream ductal dilation was found on follow‐up pancreatograms, the next stent was replaced. Repeated stenting improved outflow of pancreatic juice more effectively than one‐time stenting. Correlation between long‐term pain relief without recurrence of intraductal stones and reduction of duct diameter was also shown. Stent occlusion was observed in 14 of 30 stents. Stent occlusion was frequently associated with recurrence of pancreatitis and intraductal stones, and was also associated with morphologic changes in the pancreatic ductal system. Although there were no significant differences between stent patency of the initial stents and that of the next stents, stent patency of 10‐Fr stents was superior to that of 7‐Fr stents. 10‐Fr stents should be removed within 8 weeks and 7‐Fr stents should be removed within 4 weeks for the prevention of stent occlusion. Repeated stenting with short‐term stenting is therefore considered a safe and effective protocol of endoscopic pancreatic stenting.  相似文献   
6.
贲门失驰缓症介入治疗的疗效评价   总被引:1,自引:0,他引:1  
目的:评价贲门失弛缓症球囊扩张介入治疗的疗效。方法:对20例贲门失驰缓症患者行球囊扩张术。结果:20例患者共进行了31次球囊扩张,人均1.5次(其中12例扩张1次,5例扩张2次,3例扩张3次)。术后患者吞咽困难明显缓解,主要并发症为疼痛和返流。术后随访无症状期为3-13个月。结论:球囊扩张术是治疗门失弛缓症的有效方法。  相似文献   
7.
目的:应用高频超声观察冠心病(CAD)患者,经阿托伐他汀治疗后对肱动脉内皮依赖性舒张功能(EDD)的改善作用。方法:经冠脉造影(CAG)确诊为CAD患者59例,利用高频超声血管技术检测阿托伐他汀对CAD患者治疗前后肱动脉EDD的疗效。结果:阿托伐他汀治疗2年后,EDD比治疗前有明显改善(P〈0.05),与对照组相比无显著性差异(P〉0.05)。常规治疗组治疗2年后,EDD无明显改善(P〉0.05),与阿托伐他汀组治疗后及对照组相比差异有显著性(P〈0.05)。结论:阿托伐他汀具有改善EDD的作用。  相似文献   
8.
To determine whether dilation of large coronary arteries normalizes shear during increased flow following brief occlusion, six dogs were instrumented to measure aortic and left ventricular pressures, left circumflex coronary artery external diameter, and coronary blood flow. The coronary artery was occluded for 15 or 30 s. Data were obtained before and after blockade of EDRF synthesis with nitro-L-arginine. Internal coronary artery diameter and wall shear were calculated on a moment-to-moment basis and the area under the flow curve was measured. Peak flow and shear rate were unaffected by NLA or by the occlusion duration. Flow curve area increased with the duration of occlusion. Internal and external diameters increased significantly for 15 s occlusions before NLA (by 4 ± 1% in external diameter and by 11 ± 4% in internal diameter) and for 30 s occlusions before NLA (by 5 ± 1% in external diameter and by 14 ± 5% in internal diameter) but not after NLA. Adenosine infusions of 0.05, 0.10, 0.50, and 1.0 μmol/kg/min were also used to dilate the coronary arteries. With each infusion, flow, shear and diameter were allowed to reach steady state. Steady state shear was reduced only slightly and did not approach the baseline state. We conclude that increased shear rate causes an increase in coronary artery diameter which is EDRF dependent. Increased coronary artery diameter during reactive hyperemia and adenosine infusions did not normalize wall shear.  相似文献   
9.
目的探索如何提高新福林滴眼液的治疗指数。方法我们用10%-40μl、10%-10μl、2.5%-40μl、2.5%-10μl4组新福林滴眼液给16名健康大学生分次进行扩瞳试验,观察它们的扩瞳效果及用药后心率、血压的变化。结果同一容量10%比2.5%新福林扩瞳效果强。同一浓度10μl与40μl新福林扩瞳效果相似。10%-10μl与2.5%-40μl其新福林含量相等,但前者扩瞳效果要优于后者。4组新福林眼液对实验对象的心率和血压均无显著影响。结论采用高浓度小滴量新福林眼液扩瞳,不仅可以减少滴眼液的用量,提高其生物可用度,更重要的是可使其治疗指数得以显著提高。  相似文献   
10.
Background: Gastrointestinal strictures are the most often and serious complication in Crohn's disease. Because of the frequent postoperative recurrence in Crohn's disease, endoscopic therapy of gastrointestinal stricture is one of the best therapeutic options. Method: The present study sets out the results from a prospective study of endoscopic dilation therapy on 48 Crohn's disease patients with severe gastrointestinal stenoses. All patients who could not undergo endoscopic balloon dilation therapy (EBD) were operated on. Results: Long‐term success was attained in 32 of the 48 patients; cumulative avoidance of surgery after EBD was 86% at one year and 71% at three. Second, the most hazardous factor was recurrent inflammation causing restenosis. Patients who had strictures with oral luminal dilatation and patients with frequent recurrence had a tendency to be operated on. As a complication, perforation occurred in two cases (3.3%). Conclusions: EBD therapy for Crohn's stricture in the gastrointestinal tract is recommended before surgical intervention.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号